PMID- 36510177 OWN - NLM STAT- MEDLINE DCOM- 20221214 LR - 20221222 IS - 1471-2369 (Electronic) IS - 1471-2369 (Linking) VI - 23 IP - 1 DP - 2022 Dec 12 TI - Association between uric acid level and contrast-induced acute kidney injury in patients with type 2 diabetes mellitus after coronary angiography: a retrospective cohort study. PG - 399 LID - 10.1186/s12882-022-03030-z [doi] LID - 399 AB - BACKGROUND: This study assessed the predictive value of uric acid (UA) for contrast-induced acute kidney injury (CI-AKI) in patients with type 2 diabetes mellitus (T2DM) who underwent coronary angiography (CAG). A nomogram to aid in the prediction of CI-AKI was also developed and validated, and the construction of a prognostic nomogram combined with clinical features was attempted. METHODS: This study retrospectively enrolled T2DM patients who underwent CAG between December 2019 and December 2020 at the Affiliated Zhongda Hospital of Southeast University. Multivariable logistic regression analysis was used for the analysis of clinical outcomes. Receiver operating characteristic (ROC) analyses were performed to determine the area under the ROC curve (AUC) and the cut-off points for continuous clinical data. The prediction accuracies of models for CI-AKI were estimated through Harrell's concordance indices (C-index). Nomograms of the prognostic models were plotted for individualized evaluations of CI-AKI in T2DM patients after CAG. RESULTS: A total of 542 patients with T2DM who underwent CAG were included in this study. We found that a high UA level (>/= 425.5 micromol/L; OR = 6.303), BUN level (>/= 5.98 mmol/L; OR = 3.633), Scr level (>/= 88.5 micromol/L; OR = 2.926) and HbA1C level (>/= 7.05%; OR = 5.509) were independent factors for CI-AKI in T2DM patients after CAG. The nomogram model based on UA, BUN, Scr and HbA1C levels presented outstanding performance for CI-AKI prediction (C-index: 0.878). Decision curve analysis (DCA) showed good clinical applicability in predicting the incidence of CI-AKI in T2DM patients who underwent CAG. CONCLUSION: High UA levels are associated with an increased incidence of CI-AKI in T2DM patients after CAG. The developed nomogram model has potential predictive value for CI-AKI and might serve as an economic and efficient prognostic tool in clinical practice. CI - (c) 2022. The Author(s). FAU - Tang, Haixia AU - Tang H AD - Institute of Nephrology, Zhongda Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China. FAU - Chen, Haoying AU - Chen H AD - Department of Ultrasonography, Taizhou central hospital, Taizhou university hospital, Ningbo, China. FAU - Li, Zuolin AU - Li Z AD - Institute of Nephrology, Zhongda Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China. FAU - Xu, Shengchun AU - Xu S AD - Institute of Nephrology, Zhongda Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China. FAU - Yan, Gaoliang AU - Yan G AD - Department of Cardiology, Zhongda Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China. FAU - Tang, Chengchun AU - Tang C AD - Department of Cardiology, Zhongda Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China. FAU - Liu, Hong AU - Liu H AD - Institute of Nephrology, Zhongda Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China. jstzliu@sina.com. LA - eng GR - 82000648/National Natural Science Foundation of China/ PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20221212 PL - England TA - BMC Nephrol JT - BMC nephrology JID - 100967793 RN - 268B43MJ25 (Uric Acid) SB - IM MH - Humans MH - Coronary Angiography/adverse effects MH - Uric Acid MH - Retrospective Studies MH - *Diabetes Mellitus, Type 2/complications MH - *Acute Kidney Injury/chemically induced/diagnostic imaging/epidemiology PMC - PMC9746209 OTO - NOTNLM OT - Contrast induced-acute kidney injury OT - Coronary angiology OT - Nomogram OT - Type 2 diabetes mellitus OT - Uric acid COIS- The authors declare that they have no competing interests. EDAT- 2022/12/13 06:00 MHDA- 2022/12/15 06:00 PMCR- 2022/12/12 CRDT- 2022/12/12 23:46 PHST- 2022/08/06 00:00 [received] PHST- 2022/12/05 00:00 [accepted] PHST- 2022/12/12 23:46 [entrez] PHST- 2022/12/13 06:00 [pubmed] PHST- 2022/12/15 06:00 [medline] PHST- 2022/12/12 00:00 [pmc-release] AID - 10.1186/s12882-022-03030-z [pii] AID - 3030 [pii] AID - 10.1186/s12882-022-03030-z [doi] PST - epublish SO - BMC Nephrol. 2022 Dec 12;23(1):399. doi: 10.1186/s12882-022-03030-z.